Papillary Carcinoma
Showing 1 - 25 of 8,345
Asymptomatic Papillary Microcarcinomas on Patient Survival
Active, not recruiting
- Papillary Carcinoma
- Questionnaire
-
Toulouse, FranceUHToulouse
May 15, 2023
Columnar Cell Variant Thyroid Gland Papillary Carcinoma, Follicular Variant Thyroid Gland Papillary Carcinoma, Metastatic
Active, not recruiting
- Columnar Cell Variant Thyroid Gland Papillary Carcinoma
- +25 more
- Laboratory Biomarker Analysis
- +3 more
-
Torrance, California
- +6 more
Jan 12, 2023
A Gene Hunting Study for Familial Papillary Thyroid Cancer
Recruiting
- Thyroid
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Oct 13, 2022
Papillary Thyroid Carcinoma, Thermal Ablation Trial in Beijing (No Intervention)
Recruiting
- Papillary Thyroid Carcinoma
- Thermal Ablation
- No Intervention
-
Beijing, ChinaBeijing Friendship Hospital
Jul 19, 2023
Papillary Renal Cell Carcinoma Trial (Pembrolizumab, Placebo)
Not yet recruiting
- Papillary Renal Cell Carcinoma
- Pembrolizumab
- Placebo
- (no location specified)
Nov 24, 2023
Galectin-3 in Papillary Thyroid Carcinoma
Not yet recruiting
- Galactin 3-thyroid Carcinoma
- (no location specified)
Jan 26, 2023
Predict Central Lymphnode Metastasis in Thyroid Papillary
Completed
- Thyroid Papillary Carcinoma
- male
-
Guangzhou, Guangdong, ChinaSun Yat-sen Memorial Hospital of Sun Yat-Sen University
Dec 29, 2021
Tumor Deposits for Patients With Papillary Thyroid Carcinoma
Completed
- Exploring the Prognostic Value of Tumor Deposits PTC Patients
- surgery
-
Guangzhou, Guangdong, ChinaNanfang Hospital, Southern Medical University
Sep 18, 2023
Malignant Thyroid Gland Tumor, Poorly Differentiated Thyroid Gland Carcinoma, Recurrent Thyroid Gland Carcinoma Trial in Houston
Recruiting
- Malignant Thyroid Gland Neoplasm
- +6 more
- Quality-of-Life Assessment
- +3 more
-
Ann Arbor, Michigan
- +1 more
Jan 24, 2023
Thyroid Cancer, Surgery, Recurrence Trial in Beijing (Thyroxine)
Recruiting
- Thyroid Cancer
- +2 more
-
Beijing, Beijing, ChinaCancer Hospital, Chinese Academy of Medical Science
Oct 13, 2023
Clinical Factors on Prognosis of Papillary Renal Cell Carcinoma
Completed
- Carcinoma, Renal Cell
- We do not have any interventions. This study is based on obseravation.
- (no location specified)
Oct 27, 2023
18F-TFB PET/CT Scan in Differentiated Thyroid Cancer
Recruiting
- Differentiated Thyroid Gland Carcinoma
- +2 more
- Computed Tomography
- +3 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 4, 2023
Benign Thyroid Gland Tumor, Recurrent Thyroid Gland Carcinoma, Thyroid Gland Follicular Tumor of Uncertain Malignant Potential
Recruiting
- Benign Thyroid Gland Neoplasm
- +4 more
- Quality-of-Life Assessment
- Radiofrequency Ablation
-
Houston, TexasM D Anderson Cancer Center
Sep 3, 2022
Fascial Versus Standard Neck Dissection in N1b Papillary Thyroid
Completed
- Patients With Papillary Thyroid Cancer and N1b Status
- Fascial Neck Dissection
- Standard Neck Dissection
-
Rome, ItalyFondazione Policlinico Universitario Agostino Gemelli IRCCS
Mar 27, 2023
Refractory Thyroid Gland Carcinoma, Refractory Thyroid Gland Papillary Carcinoma, Refractory Thyroid Gland Follicular Carcinoma
Recruiting
- Refractory Thyroid Gland Carcinoma
- +3 more
- 177Lu-DOTA-EB-FAPI 1 radionuclide therapy
- +2 more
-
Xiamen, ChinaThe First Affiliated Hospital of Xiamen University
Nov 3, 2022
Advanced Clear Cell Renal Carcinoma (Ccrcc), Papillary Renal Cell Carcinoma (Prcc) Trial run by the National Cancer Institute
Not yet recruiting
- Advanced Clear Cell Renal Carcinoma (Ccrcc)
- Papillary Renal Cell Carcinoma (Prcc)
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Papillary Thyroid Microcarcinoma Trial in Los Angeles (Active Surveillance)
Recruiting
- Papillary Thyroid Microcarcinoma
- Active Surveillance
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Jul 5, 2022
Papillary Thyroid Carcinoma Trial in Guangzhou (retro-auricular single-site endoscopic thyroidectomy, traditional open surgery
Recruiting
- Papillary Thyroid Carcinoma
- retro-auricular single-site endoscopic thyroidectomy
- traditional open surgery thyroidectomy
-
Guangzhou, Guangdong, ChinaSun Yat-Sen University Cancer Center
Apr 17, 2022
Cross-sectional Case and Control Study on Quality of Life,
Recruiting
- Papillary Thyroid Carcinoma
- Thyroid Cancer
- Thyroid lobectomy via trans-axillary approach
- Thyroid lobectomy via open approach
-
Beijing, Beijing, ChinaDepartment of General Surgery, Peking Union Medical College Hosp
Jul 5, 2023
Papillary Thyroid Carcinoma Trial in Guangzhou (Retro-Auricular Single-Site Endoscopic Thyroidectomy, Transoral Endoscopic
Recruiting
- Papillary Thyroid Carcinoma
- Retro-Auricular Single-Site Endoscopic Thyroidectomy
- +2 more
-
Guangzhou, Guangdong, ChinaSun Yat-Sen University Cancer Center
Mar 6, 2023
Papillary Thyroid Microcarcinoma, Thyroid, Thyroid Cancer Trial in New York (Percutaneous Laser Ablation (PLA))
Recruiting
- Papillary Thyroid Microcarcinoma
- +2 more
- Percutaneous Laser Ablation (PLA)
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jul 14, 2022
Surgical Management of Advanced Thyroid Cancer
Recruiting
- Thyroid Carcinoma
- +6 more
- Thyroidectomy with or without lymphadenectomy or multivisceral resection
-
Rome, ItalyFondazione Policlinico Universitario Agostino Gemelli IRCCS
Mar 31, 2023
Thyroid Cancer Trial (Endoscopic surgery;)
Not yet recruiting
- Thyroid Cancer
- Endoscopic surgery;
- (no location specified)
Jun 30, 2022
Papillary Renal Cell Carcinoma Type 2 Trial in France (Axitinib Oral Tablet [Inlyta], Pembrolizumab Injection [Keytruda])
Recruiting
- Papillary Renal Cell Carcinoma Type 2
- Axitinib Oral Tablet [Inlyta]
- Pembrolizumab Injection [Keytruda]
-
Angers, France
- +11 more
Aug 26, 2022